Lista de obras - Ralf Wagner - Dominio Público Uruguay

A Step toward High-Energy Silicon-Based Thin Film Lithium Ion Batteries

artículo científico publicado en 2017

A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1

artículo científico publicado en 2014

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

artículo científico publicado en 2008

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

artículo científico publicado en 2008

An Intrinsically Safe Gel Polymer Electrolyte Comprising Flame Retarding Polymer Matrix for Lithium Ion Battery Application

article

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

artículo científico publicado en 2020

Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses

artículo científico publicado en 2004

Changing Established Belief on Capacity Fade Mechanisms: Thorough Investigation of LiNi1/3Co1/3Mn1/3O2 (NCM111) under High Voltage Conditions

article

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

scientific article published on 15 October 2019

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C

artículo científico publicado en 2012

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.

artículo científico publicado en 2012

Counterintuitive Role of Magnesium Salts as Effective Electrolyte Additives for High Voltage Lithium-Ion Batteries

article

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

artículo científico publicado en 2011

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates

artículo científico publicado en 2008

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

artículo científico publicado en 2008

Evaluation of Allylboronic Acid Pinacol Ester as Effective Shutdown Overcharge Additive for Lithium Ion Cells

article

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

artículo científico publicado en 2006

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

artículo científico publicado en 2017

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

artículo científico publicado en 2015

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

artículo científico publicado en 2006

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

artículo científico publicado en 2019

High Voltage LiNi0.5Mn1.5O4/Li4Ti5O12 Lithium Ion Cells at Elevated Temperatures: Carbonate- versus Ionic Liquid-Based Electrolytes

article

Identification of alkylated phosphates by gas chromatography-mass spectrometric investigations with different ionization principles of a thermally aged commercial lithium ion battery electrolyte

artículo científico publicado en 2015

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.

artículo científico publicado en 2011

Impact of Selected LiPF6 Hydrolysis Products on the High Voltage Stability of Lithium-Ion Battery Cells.

artículo científico publicado en 2016

Improved NYVAC-based vaccine vectors

artículo científico publicado en 2011

In operando X-shaped cell online electrochemical mass spectrometry (OEMS): New online analysis enables insight into lab scale lithium ion batteries during operation

article

Innovative, Non-Corrosive LiTFSI Cyanoester-Based Electrolyte for Safer 4 V Lithium-Ion Batteries

article

Learning from Overpotentials in Lithium Ion Batteries: A Case Study on the LiNi1/3Co1/3Mn1/3O2(NCM) Cathode

article

Magnesium-based additives for the cathode slurry to enable high voltage application of lithium-ion batteries

article

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

artículo científico publicado en 2016

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

article

Proceedings of the Frontiers of Retrovirology Conference 2016.

artículo científico publicado en 2016

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

article

Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.

artículo científico publicado en 2015

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.

artículo científico publicado en 2012

The truth about the 1st cycle Coulombic efficiency of LiNi1/3Co1/3Mn1/3O2 (NCM) cathodes

article

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

artículo científico publicado en 2014

Lista de obras de Ralf Wagner

A Step toward High-Energy Silicon-Based Thin Film Lithium Ion Batteries

A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

An Intrinsically Safe Gel Polymer Electrolyte Comprising Flame Retarding Polymer Matrix for Lithium Ion Battery Application

Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials

Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responses

Changing Established Belief on Capacity Fade Mechanisms: Thorough Investigation of LiNi1/3Co1/3Mn1/3O2 (NCM111) under High Voltage Conditions

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC"

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.

Counterintuitive Role of Magnesium Salts as Effective Electrolyte Additives for High Voltage Lithium-Ion Batteries

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

Evaluation of Allylboronic Acid Pinacol Ester as Effective Shutdown Overcharge Additive for Lithium Ion Cells

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci

Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates

Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses

High Voltage LiNi0.5Mn1.5O4/Li4Ti5O12 Lithium Ion Cells at Elevated Temperatures: Carbonate- versus Ionic Liquid-Based Electrolytes

Identification of alkylated phosphates by gas chromatography-mass spectrometric investigations with different ionization principles of a thermally aged commercial lithium ion battery electrolyte

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.

Impact of Selected LiPF6 Hydrolysis Products on the High Voltage Stability of Lithium-Ion Battery Cells.

Improved NYVAC-based vaccine vectors

In operando X-shaped cell online electrochemical mass spectrometry (OEMS): New online analysis enables insight into lab scale lithium ion batteries during operation

Innovative, Non-Corrosive LiTFSI Cyanoester-Based Electrolyte for Safer 4 V Lithium-Ion Batteries

Learning from Overpotentials in Lithium Ion Batteries: A Case Study on the LiNi1/3Co1/3Mn1/3O2(NCM) Cathode

Magnesium-based additives for the cathode slurry to enable high voltage application of lithium-ion batteries

Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens

Priming with a potent HIV-1 DNA vaccine frames the quality of immune responses prior to a poxvirus and protein boost

Proceedings of the Frontiers of Retrovirology Conference 2016.

Replication-competent NYVAC-KC yields improved immunogenicity to HIV-1 antigens in rhesus macaques, compared to non-replicating NYVAC

Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.

The truth about the 1st cycle Coulombic efficiency of LiNi1/3Co1/3Mn1/3O2 (NCM) cathodes

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.